TY  - GEN
AU  - Brugnatelli,S
AU  - Riccardi,A
AU  - Ucci,G
AU  - Mora,O
AU  - Barbarano,L
AU  - Piva,N
AU  - Piccinini,L
AU  - Bergonzi,C
AU  - De Paoli,A
AU  - Di Stasi,M
AU  - Rinaldi,E
AU  - Trotti,G
AU  - Petrini,M
AU  - Ascari,E
TI  - Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma
SN  - 0007-0920
PY  - 1996///0604
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents, Alkylating
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Cyclophosphamide
KW  - Drug Administration Schedule
KW  - Epirubicin
KW  - Female
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Male
KW  - Melphalan
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Myeloproliferative Disorders
KW  - chemically induced
KW  - Peptichemio
KW  - Prednisone
KW  - Recombinant Proteins
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bjc.1996.138
ER  -